These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35544744)

  • 1. News from CROI 2022 - caveats using antiretrovirals as HIV prophylaxis.
    Barreiro P; Soriano V
    AIDS Rev; 2022 Apr; 24(2):98-99. PubMed ID: 35544744
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PrEP for HIV prevention, major tool of the global diversified prevention strategy].
    Slama L
    Rev Prat; 2021 Nov; 71(9):957-959. PubMed ID: 35147307
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence supports use of on-demand PrEP for HIV prevention.
    Chow EPF; Fairley CK
    Lancet HIV; 2022 Aug; 9(8):e524-e526. PubMed ID: 35772418
    [No Abstract]   [Full Text] [Related]  

  • 5. Cabotegravir (Apretude) for Pre-exposure Prophylaxis for HIV Type 1 Infection.
    El-Haddad A; Erlich D
    Am Fam Physician; 2023 May; 107(5):545-546. PubMed ID: 37192084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral pre-exposure prophylaxis for HIV prevention is highly effective in community settings.
    Bazzi AR
    Evid Based Med; 2016 Jun; 21(3):99. PubMed ID: 27029888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress and new challenges. HIV: the cure moves closer].
    Leiner P
    MMW Fortschr Med; 2015 Feb; 157(2):29. PubMed ID: 25743508
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
    Abdool Karim Q; Bayer R
    Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
    [No Abstract]   [Full Text] [Related]  

  • 9. Key data from AIDS 2022.
    Owen R; Maan I; Waters L
    HIV Med; 2023 May; 24(5):515-520. PubMed ID: 36349523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and AIDS in Africa: good news and bad news.
    Cumming RG
    Med J Aust; 2012 Mar; 196(5):309. PubMed ID: 22432659
    [No Abstract]   [Full Text] [Related]  

  • 11. [To finish theoretically with AIDS].
    Nau JY
    Rev Med Suisse; 2008 Dec; 4(183):2705. PubMed ID: 19157288
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    Landovitz RJ; Grinsztejn B
    J Infect Dis; 2016 May; 213(10):1519-20. PubMed ID: 26681779
    [No Abstract]   [Full Text] [Related]  

  • 13. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
    Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
    J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of virtual CROI 2021.
    Hayward P
    Lancet HIV; 2021 Apr; 8(4):e184. PubMed ID: 33794180
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV pre-exposure prophylaxis (PrEP).
    Tumarkin E; Siedner MJ; Bogoch II
    BMJ; 2019 Jan; 364():k4681. PubMed ID: 30655299
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond the Magic Bullet: What Will It Take to End the AIDS Epidemic?
    El-Sadr WM
    Am J Public Health; 2021 Jul; 111(7):1234-1236. PubMed ID: 34110928
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementing the Trump Administration's "Ending the HIV Epidemic" Plan in the Southern United States.
    Hiers K
    Am J Public Health; 2020 Jan; 110(1):32-33. PubMed ID: 31800275
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada.
    Billick MJ; Fisher KN; Myers S; Tan DHS; Bogoch II
    J Acquir Immune Defic Syndr; 2023 Nov; 94(3):211-213. PubMed ID: 37850980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights from IAS 2015.
    Hayward P
    Lancet Infect Dis; 2015 Sep; 15(9):1012. PubMed ID: 26333333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.